Capital Injection to Support Chinese State-Owned Insurers' Role for Economy, S&P Says
MT Newswires Live
Sep 08
A capital injection worth 70 billion yuan should anchor the ability of five Chinese state-owned insurers' capacity to anchor the economy and address current and potential bottlenecks, S&P Global Ratings said in a Tuesday release.
The injection will boost the sector's financial resilience as it faces heightened geopolitical and market volatility, S&P credit analyst WenWen Chen said.
The support, which is a rare move from the Ministry of Finance, points to the state's assurance in aiding the financial system, S&P said.
The injection provides a modest boost to insurers' sufficient solvency levels while giving them more leeway to weather a changing macro and regulatory environment, according to the rating agency.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.